Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report
José Alexandre S. Crippa(Conselho Nacional de Desenvolvimento Científico e Tecnológico), Jaime E. C. Hallak(Universidade de Ribeirão Preto), Rocío Martín‐Santos(Centro de Investigación Biomédica en Red de Salud Mental), Geraldo F. Busatto(Universidade de São Paulo), Paolo Fusar‐Poli(King's College London), Zerrin Atakan(University of London), Lauro Wichert‐Ana(Universidade de Ribeirão Preto), Antônio Waldo Zuardi(Universidade de Ribeirão Preto), Thiago Borduqui Ferrari(Center for Neurosciences), Philip McGuire(Warneford Hospital), Maria Cecília Freitas-Ferrari(Center for Neurosciences), Marcus Vinı́cius Simões(Universidade de Ribeirão Preto), Alaor Santos Filho(Center for Neurosciences), Sagnik Bhattacharyya(King's College London), Fábio Ls Duran(Universidade de São Paulo), Guilherme Nogueira Derenusson(Center for Neurosciences)
Cited by 530
Related Papers
Age at onset of mental disorders worldwide: large-scale meta-analysis of 192 epidemiological studies
|Molecular Psychiatry|2021|3.6k
Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial
|Psychological Medicine|2018|819
Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients
|Neuropsychopharmacology|2011|763
Cognitive impairment in schizophrenia: aetiology, pathophysiology, and treatment
|Molecular Psychiatry|2023|684
Impact of coronavirus syndromes on physical and mental health of health care workers: Systematic review and meta-analysis
|Journal of Affective Disorders|2020|659